Lexaria Bioscience Corp. — Director's Dealing 2015

Dec 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2015-12-16

Reporting Person: Baxter Nicholas W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-16	Common Shares	A	20000	—	Acquired	220000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-07-11	Stock Options	$0.32	A	15000	Acquired	2016-07-11	Common Shares (15000)	Direct
2014-12-23	Stock Options	$0.1	A	10000	Acquired	2019-12-23	Common Shares (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	200000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.32	2016-07-11	Common Shares (150000)	150000	Direct
Stock Options	$0.1	2019-12-23	Common Shares (100000)	265000	Direct

Footnotes

F1: Adjusted to forward 1.1 split

F2: Adjusted price to forward 1.1 split